$ENZC - πŸ’₯DUE DILIGENCEπŸ’₯

This is the official thread that I will build on to capture all if the DD that others and I have done.

If anyone wonders where to find the DD on @enzolytics, point them here πŸ‘‡
#1 - Here is a very comprehensive DD package created by a fellow shareholder. Besides including PRs all on one site, it has a lot of relevant videos to get you started

notion.so/ENZC-Latest-Ne…

$ENZC
#2 - their website is a great source if you are just getting your feet wet and want background on their technology, facilities, and executives
enzolytics.com

Make sure to also follow the executives on Twitter;

@enzolytics
@drgauravchandra (COO and VP of R&D)

$ENZC
#3 - @yatesinvesting has also compiled some of the DD into PowerPoint. It's a great summary of our milestones & Intel partnership. Link below:

1drv.ms/p/s!AseTmu6x6-…
#4 - On April 14th, 2021. CEO Charles Cotropia gave a very comprehensive summary of the company. This is a MUST watch.

Watch the video here:


Slides attached here:
notion.so/3763b79a47bd44…

$ENZC
#5 - On May 27, 2021 @intel Senior Leadership, @cliftonroberts and Nikhil Desphande, and @enzolytics COO, Dr. Gaurav Chandra had a panel discussion going over how $ENZC is using artificial intelligence to ultimately develop cures for diseases.


$ENZC
#6 - @intel published a whitepaper on how #AI can be used to develop CURES for many deadly diseases. This is an absolutely "must read" to understand how we will be pioneering Healthcare 2.0.

intel.com/content/www/us…
#7 - I have also interviewed and shared my opinions.

May 2021 Interview:


January 2021 Interview:


$ENZC
#9 - Drug Development milestones.

On April 19th, 2021, the company issued a very comprehensive PR detailing their scientific milestones.

otcmarkets.com/stock/ENZC/new…

From this PR, I created a Pipeline chart to visualize. I will update this chart once per month; Image
#10 - This is basic but critical to understand. We have 3 platforms/technogies;

A) #AI to discover conserved sites on viruses

B) Human monoclonal antibodies to target a wide range of viruses. #HIV #COVID #HTLV etc (CURES)

C) IPF, which is used as an immuno-enhancer. (NOT CURE) Image
#11 - Using #AI the company intends on finding anf patenting conserved sites on all of these diseases.

We have only scratched the surface with #HIV #COVID and #HTLV. The company will attempt to develop CURES for many more, including #influenza (flu) #HSV (herpes), Ebola, etc. ImageImage
#12 - The company has many partnerships and is looking to expand further with other pharmaceutical companies.

@GenScript - mAb production
@STCBiologics - Clinical Studies
@intel, @scientific_usa - AI
Uni Strasbourg - in-vitro studies
@CNPRCresearch - animal studies Image
#13 - Clone3 (CL3hmAb) is our mAb for #HIV. In-vitro studies show it to be unmatched at how effective it is. It's been studied in 6 universities all showing 95% effective against multiple strains of HIV. This therapy could be used to CURE/eradicate HIV.

ImageImageImageImage
#14 - CL3 was the first #HIV mAb, but not the last. With a cocktail of HIV antibodies HIV neutralization will likely be >95% effective now which promises to CURE the disease. Once commercial, this drug alone could bring in $105B within 11 years.

$ENZC ImageImageImage
#15 - Our ITV-1 #IPF drug is going through EMA clinical trials. A smaller dose was trialed and discovered to be equally effective without any serious side effects when compared to Tamiflu. ITV-1 is an immuno supporter for #HIV patients, cold/flu and possibly #COVID ImageImageImageImage
#16 - @enzolytics enters into first distribution and licensing agreement for their #ITV1 drug. Clinical trials are currently planned in Europe (EMA). Once approved, they will go for FDA approval as well.

otcmarkets.com/stock/ENZC/new… ImageImageImageImage
#17 Regarding #SARSCoV2 monoclonal antibody CURE. Watch this video where they talk about engaging @US_FDA to fast track clinical studies. Should be done by year end. Animal trials start this month, June 2021. According to the vid.

Watch 38:55 - 41:00. πŸ‘€
ImageImageImage
#18 - During the most recent interview, COO addressed additional debilitating diseases and #Cancer was mentioned being a target. I suspect a antibody drug conjugate (ADC) but we don't have an official announcement yet.

Watch 42:42 - 44:20 πŸ‘€
Image
#19 - On June 7th, the company issues a PR highlighting a protocol to tackle existing and future pandemics, including the new #H10N3 bird flu. The company reaffirms objective to strengthen its IP Portfolio for various diseases and seeks partnerships.

otcmarkets.com/stock/ENZC/new… ImageImageImageImage
#20 - Since reverse merging on December 1st, 2020, the company formed two subsidiaries; Virogentics and Biogenysis with intention to license their technologies. The company is actively seeking and dialouging with pharmaceutical companies, some that are milestone linked. ImageImage
#21 - On Nov 10, 2020, Ronald Moss was appointed to ENZC medical advisory board. He's worked for major pharma company $MRK (NASDAQ), serves as Chief Medical officer at $ADMP (NASDAQ), and worked at @NIH. He has years of experience taking drugs through @US_FDA clinical trials. ImageImageImageImage
#22 - On July 20th, 2021, the company announced a LOI with Creative Biolabs, inc. to license and commercialize the first treatment ever for the #HTLV Virus which impacts 10 - 20 Million people globally ImageImageImageImage
#23 - On July 21st, 2021 the company announces a partnership with Lonza Group $LZAGF, a $54 Billion company, to expedite the development and production of HIV and SARS-CoV-2 monoclonal antibodies. The expectation is that time to clinical trials will be significantly reduced. ImageImageImageImage
#24 - On July 22nd, 2021 @jameshicks held the 3rd Interview with @enzolytics followed by a zoomcall.

Watch the Recap here:


Notes from both meetings below:

Thank you @foxypenny for putting together you notes 🀌 ImageImageImageImage
#25 - Partnerships (UPDATE). Image

β€’ β€’ β€’

Missing some Tweet in this thread? You can try to force a refresh
γ€€

Keep Current with π†π¨ππŸπšπ­π‘πžπ« π‚πšπ©π’π­πšπ₯

π†π¨ππŸπšπ­π‘πžπ« π‚πšπ©π’π­πšπ₯ Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(